MPP9 (Membrane Palmitoylated Protein 9) is involved in various cellular processes, particularly in the modulation of cell signaling pathways that are critical for cell communication, proliferation, and survival. It is part of the MAGUK (membrane-associated guanylate kinase) protein family, known for their role in mediating signal transduction at cell junctions and interfaces. MPP9 plays a specific role in the structural organization and functional regulation of protein complexes at cell membranes, facilitating efficient signal transduction and cellular responses to external stimuli. Through its interactions with other membrane proteins, MPP9 helps maintain the integrity of cell-cell interactions and is implicated in processes such as cellular adhesion and the maintenance of epithelial barrier function.
The inhibition of MPP9 can lead to disruptions in cellular communication and signal transduction, potentially affecting tissue integrity and cellular homeostasis. One mechanism of MPP9 inhibition could involve the direct interference with its ability to bind to other membrane proteins or signaling molecules. This could be achieved through the competitive binding of inhibitory molecules that mimic the natural binding partners of MPP9, thereby preventing it from forming functional complexes necessary for its role in signal transduction. Another potential mechanism for inhibiting MPP9 involves altering its expression at the transcriptional level. Specific transcription factors or epigenetic modifications could downregulate the expression of the MPP9 gene, leading to reduced protein levels and subsequently diminishing its functional presence at the cellular junctions. Additionally, post-translational modifications such as phosphorylation, ubiquitination, or palmitoylation could modify the stability, cellular localization, or binding affinity of MPP9, further impacting its effectiveness in maintaining cellular signaling and structural integrity. Understanding these inhibitory mechanisms is critical for comprehending the regulatory roles of MPP9 in cellular signaling networks and their implications in various physiological and pathological contexts.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Can inhibit PI3K, which is part of signaling pathways that may involve MPP9 or its interacting proteins. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, potentially affecting pathways associated with MPP9. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Targets p38 MAPK, possibly affecting MPP9-associated signaling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor that might modulate pathways where MPP9 plays a role. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, another kinase in pathways that may interact with MPP9. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, potentially influencing pathways where MPP9 is involved. | ||||||
Pyrrolidinedithiocarbamic acid ammonium salt | 5108-96-3 | sc-203224 sc-203224A | 5 g 25 g | $33.00 $64.00 | 11 | |
NF-kappaB inhibitor, potentially influencing transcription of genes associated with MPP9. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
Calcium chelator that can affect calcium-dependent pathways and proteins associated with MPP9. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Inhibits NF-kappaB activation, potentially affecting MPP9-associated pathways. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
A tyrosine kinase inhibitor, which might influence pathways involving MPP9. | ||||||